Archiv der Kategorie ‘Initial Recommendation‘

Shire plc (SHPG) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Sarepta Therapeutics (SRPT) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Raptor Pharma (RPTP) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Novavax (NVAX) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Michael Kors (KORS) Initial Recommendation Buy Analyst rating from Maxim Group

Wednesday, den 30. October 2013

Jazz Pharma (JAZZ) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Kythera Biopharma (KYTH) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Hipcricket (HIPP) Initial Recommendation Buy Analyst rating from Ladenburg Thalmann

Wednesday, den 30. October 2013

Hannon Armstrong Sust. Infr. (HASI) Initial Recommendation Buy Analyst rating from UBS

Wednesday, den 30. October 2013

Endo Health (ENDP) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Forest Labs (FRX) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Ecolab (ECL) Initial Recommendation Buy Analyst rating from UBS

Wednesday, den 30. October 2013

DS Healthcare Group (DSKX) Initial Recommendation Buy Analyst rating from Aegis Capital

Wednesday, den 30. October 2013

Biogen Idec (BIIB) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Amarin (AMRN) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Alkermes (ALKS) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Aegerion Pharma (AEGR) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Acorda Therapeutics (ACOR) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Potbelly (PBPB) Initial Recommendation Neutral Analyst rating from Robert W. Baird

Tuesday, den 29. October 2013

Potbelly (PBPB) Initial Recommendation Mkt Perform Analyst rating from William Blair

Tuesday, den 29. October 2013

Omnicom (OMC) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

OCI Partners (OCIP) Initial Recommendation Overweight Analyst rating from Barclays

Tuesday, den 29. October 2013

Nielsen (NLSN) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

McKesson (MCK) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Moody’s (MCO) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

McGraw-Hill Financial (MHFI) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Gamestop (GME) Initial Recommendation Buy Analyst rating from Stifel

Tuesday, den 29. October 2013

Cherry Hill Mortgage (CHMI) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

ClickSoftware (CKSW) Initial Recommendation Outperform Analyst rating from Northland Capital

Tuesday, den 29. October 2013

CBS (CBS) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Cherry Hill Mortgage (CHMI) Initial Recommendation Overweight Analyst rating from Barclays

Tuesday, den 29. October 2013

Cardinal Health (CAH) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

AmerisourceBergen (ABC) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Tekmira Pharma (TKMR) Initial Recommendation Buy Analyst rating from Maxim Group

Tuesday, den 18. June 2013

T-Mobile US (TMUS) Initial Recommendation Hold Analyst rating from Canaccord Genuity

Tuesday, den 18. June 2013

Quintiles Transnational (Q) Initial Recommendation Neutral Analyst rating from Robert W. Baird

Tuesday, den 18. June 2013

Momenta Pharma (MNTA) Initial Recommendation Buy Analyst rating from WallachBeth

Tuesday, den 18. June 2013

Huntington Ingalls (HII) Initial Recommendation Hold Analyst rating from Stifel

Tuesday, den 18. June 2013

Fusion-io (FIO) Initial Recommendation Buy Analyst rating from Needham

Tuesday, den 18. June 2013

Arthur J. Gallagher (AJG) Initial Recommendation Buy Analyst rating from Compass Point

Tuesday, den 18. June 2013

Brown & Brown (BRO) Initial Recommendation Buy Analyst rating from Compass Point

Tuesday, den 18. June 2013

T-Mobile US (TMUS) Initial Recommendation Neutral Analyst rating from Robert W. Baird

Monday, den 17. June 2013

Portola Pharma (PTLA) Initial Recommendation Outperform Analyst rating from William Blair

Monday, den 17. June 2013

EQT Midstream Partners (EQM) Initial Recommendation Outperform Analyst rating from RBC Capital Mkts

Monday, den 17. June 2013

ChannelAdvisor (ECOM) Initial Recommendation Buy Analyst rating from Stifel

Monday, den 17. June 2013